Cargando…
Biochemotherapy for the treatment of metastatic malignant melanoma: a clinical practice guideline
QUESTIONS: What is the role of biochemotherapy in the treatment of metastatic malignant melanoma? What are the adverse effects and effects on quality of life of biochemotherapy as a treatment option? For the purposes of this report, “biochemotherapy” is defined as a therapeutic regimen that includes...
Autores principales: | Verma, S., Petrella, T., Hamm, C., Bak, K., Charette, M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Multimed Inc.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365480/ https://www.ncbi.nlm.nih.gov/pubmed/18454183 |
Ejemplares similares
-
Temozolomide for the treatment of metastatic melanoma
por: Quirbt, I., et al.
Publicado: (2007) -
Single-agent interleukin-2 in the treatment of metastatic melanoma
por: Petrella, T., et al.
Publicado: (2007) -
Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes
por: Håkansson, A, et al.
Publicado: (2001) -
Dose-intensive chemotherapy with growth factor or autologous bone marrow or stem-cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a clinical practice guideline
por: Verma, S., et al.
Publicado: (2008) -
Ifosfamide-based combination chemotherapy in advanced soft-tissue sarcoma: a practice guideline
por: Verma, S., et al.
Publicado: (2007)